NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways

NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathwaysNS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways, Published online: 25 June 2018; doi:10.1038/s41408-018-0098-zNS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways

Source: Blood Cancer Journal - June 25, 2018 Category: Hematology Authors: Ayumi Honda Kazuya Kuramoto Tomoko Niwa Haruna Naito Source Type: research